Our Friends from the Hearing Industries Association Talk Hearing Aid Trends, Surveys and Advocacy

Send us Fan Mail HIA president, Kate Carr, and director of public policy & advocacy, Bridget Dobyan, call in to discuss what MarkeTrak data tells us about prescription hearing aids vs. PSAPs, the state of OTC legislation, and how they’re working to advocate on behalf of patient-driven hearing healthcare. Link to full transcript

✦ Related stories ✦

Hearing Practitioner Australia·Industry news·Regulatory & legal·6w ago

Health ministers advise audiology will enter NRAS under dual profession National Board

Mandatory national registration will reshape how audiology is regulated, credentialled, and governed across Australia, with potential knock-on effects for workforce standards, scope of practice, and clinic compliance obligations.

Hearing Health Matters·Regulatory·Regulatory & legal·5d ago

U.S. Department of Labor Seeks Input on Future Standards for Occupational Hearing Loss Testing

A potential overhaul of federal occupational hearing-loss testing standards could directly reshape audiometric protocols and documentation requirements for every clinic serving industrial clients.

Hearing Review·Blog·Regulatory & legal·7d ago

Audiology and the RISE Rule: A Blessing in Disguise?

Audiology's exclusion from the RISE Rule's professional degree designation highlights an ongoing struggle for federal recognition that could affect student loan policy, workforce pipelines, and the profession's long-term standing.

The Hearing Journal Podcast·Podcast·Regulatory & legal·3y ago

Ep. 2022-10 FDA Final Rule on OTC Hearing Aids Series, Part 1: An Overview of OTC Devices With Victor Bray, PhD, and David Akbari, AuD

Drs. Victor Bray and David Akbari provide an overview of the FDA final rule on OTC hearing aids and outline implications for the audiology profession (Part 1 of 4-part series).

Hearing Tracker·Regulatory·Regulatory & legal·2mo ago

FDA Approves Regeneron's Otarmeni, First Gene Therapy for Genetic Hearing Loss

Audiologists and ENT teams treating patients with the relevant genetic form of hearing loss should become familiar with Otarmeni's approved indication and refer eligible patients to gene therapy specialists; this is a practice-changing regulatory milestone.

The Hearing Journal Podcast·Podcast·Regulatory & legal·3y ago

Ep. 2022-10 FDA Final Rule on OTC Hearing Aids Series, Part 3: The Outlook Among the Obstacles With Stephanie Czuhajewski, MPH, CFE

Stephanie Czuhajewski discusses current and potential obstacles audiologists face following the FDA's final rule on over-the-counter hearing aids (Part 3 of 4-part series).

The Hearing Journal Podcast·Podcast·Regulatory & legal·3y ago

Ep. 2022-10 FDA Final Rule on OTC Hearing Aids Series, Part 2: The New Category of Prescription Hearing Aids With Alicia Spoor, AuD

Part 2 of a 4-part Hearing Journal Podcast series on the FDA OTC hearing aid final rule, focusing on the new prescription hearing aid category with Dr. Alicia Spoor, AuD.

The Hearing Journal Podcast·Podcast·Regulatory & legal·3y ago

Ep. 2022-10 FDA Final Rule on OTC Hearing Aids Series, Part 4: A Call to Action With Kristin Davis, AuD

Dr. Kristin Davis discusses how audiologists can proactively respond to and prepare for the implications of the FDA final rule on OTC hearing aids (Part 4 of 4-part series).